This invention generally provides compounds, pharmaceutical compositions, and methods for their use, which include methods that result in increased expression in an Atoh1 gene (e.g., Hath1) in a biological cell. More specifically, the invention relates to the treatment of diseases and/or disorders that would benefit from increased Atoh1 expression, e.g. a hearing impairment or imbalance disorder associated with a loss of auditory hair cells, or a disorder associated with abnormal cellular proliferation.
本发明一般提供化合物、药物组合物及其使用方法,其中包括导致
生物细胞中 Atoh1
基因(如 Hath1)表达增加的方法。更具体地说,本发明涉及可从 Atoh1 表达增加中获益的疾病和/或失调症的治疗,例如与听觉毛细胞丧失有关的听力损伤或失调症,或与细胞异常增殖有关的失调症。